LWA
MNTA

Lenox Wealth Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Lenox Wealth Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$3K – 606
2019
Q1 		$3K Hold
200
– – ﹤0.01% 497
2018
Q4 		$2K Buy
+200
New +$2.78K ﹤0.01% 348

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Lenox Wealth Advisors's MNTA Position: Q2 2019 in Review

Lenox Wealth Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2019, closing a stake of 200 shares — an estimated $3K sold.

Lenox Wealth Advisors first reported a position in MNTA in Q4 2018 and held it in 2 quarters. The position peaked at $3K in Q1 2019. 155 funds tracked by Wall St. Rank hold MNTA as of Q2 2019.

  • Lenox Wealth Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Lenox Wealth Advisors sold 200 Momenta Pharmaceuticals, Inc. shares in Q2 2019, an estimated $3K.
  • Lenox Wealth Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
  • Lenox Wealth Advisors's Momenta Pharmaceuticals, Inc. position peaked at $3K in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2019.

Based on Lenox Wealth Advisors's 13F filing for Q2 2019, filed 12 Jul 2019.